1. Home
  2. BLTE vs CRC Comparison

BLTE vs CRC Comparison

Compare BLTE & CRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$137.17

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Logo California Resources Corporation

CRC

California Resources Corporation

HOLD

Current Price

$62.23

Market Cap

5.5B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLTE
CRC
Founded
2018
2014
Country
United States
United States
Employees
N/A
2500
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.5B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BLTE
CRC
Price
$137.17
$62.23
Analyst Decision
Strong Buy
Buy
Analyst Count
7
7
Target Price
$198.00
$72.57
AVG Volume (30 Days)
99.6K
745.5K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
2.38%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$12.37
Revenue Next Year
$492.11
N/A
P/E Ratio
N/A
$13.50
Revenue Growth
N/A
N/A
52 Week Low
$56.68
$41.88
52 Week High
$200.00
$71.98

Technical Indicators

Market Signals
Indicator
BLTE
CRC
Relative Strength Index (RSI) 31.51 46.71
Support Level $103.94 $61.52
Resistance Level $172.02 $66.35
Average True Range (ATR) 7.11 2.38
MACD -1.16 0.02
Stochastic Oscillator 7.06 33.76

Price Performance

Historical Comparison
BLTE
CRC

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About CRC California Resources Corporation

California Resources Corp is an independent oil and natural gas exploration and production company. The company has operations spread across different properties in several oil and gas exploration basins in California and Utah, such as the Midway-Sunset, South Belridge, and McKittrick fields, in the San Joaquin Basin, and other properties located in Los Angeles, Sacramento, Uinta, and the Ventura and Salinas basins. Additionally, the company is focused on maximizing the value of its land, mineral ownership, and energy expertise for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects. Its business is organized into two reporting segments: oil and natural gas, which generate maximum revenue, and carbon management.

Share on Social Networks: